United Kingdom
International medical technology executive with over 20 years of leadership experience driving growth, transformation, and value creation across EMEA, Asia, and North America. Proven track record of leading global medical device and life sciences businesses in both public and private equity-backed environments, delivering sustained revenue growth, margin expansion, and successful market development strategies. Extensive experience managing global P&L responsibility, international commercial organisations, multi-country manufacturing operations, distributor networks, and board-level governance. Recognised for successfully building, scaling, restructuring, and commercialising businesses, from early-stage ventures through to established global enterprises. A strategic and commercially focused leader who combines operational excellence with strong people leadership. Known for building high-performing teams, developing enduring stakeholder relationships, and creating cultures of accountability, innovation, and customer focus. Trusted by boards, investors, and executive teams to navigate complex business challenges and deliver measurable results. Expertise includes medical devices, biotechnology, orthopaedics, stem cell technologies, global commercial leadership, strategic planning and execution, product and market development, manufacturing, operations, R&D, organisational transformation, and change management. Significant experience working with venture capital and private equity investors, leading businesses through growth, acquisition, integration, and commercial expansion.
Executive Vice President | General Manager Outside United States | Europe and Rest of World | International Responsible for all OUS, LATAM, APAC, EMEA, commercial operations, including downstream marketing, direct, indirect and hybrid sales revenues, customer services, medical education, market development and geographic expansion. Cross functional leadership with finance, operations, clinical. Orthopaedic Medical Device, primarily in the specialty of bone infection management. Consistent, multi-year High Revenue and Profitability Growth track record. Margin Expansion. Hybrid Business Model. Multi-Geographic Leadership. High Performing Team Development. Key Opinion Leadership. BONESUPPORT™ is a Swedish medical device orthopaedic technology company dedicated to the development injectable osteoconductive biomaterials for the treatment of fragility fractures caused by osteoporosis, and bone voids or gaps caused by trauma, disease or related to surgical procedures i.e. Cysts, benign tumors, fracture malunion, joint revision, augmentation of fracture repair.
Global General Manager for Johnson Matthey Medical Devices. Leadership and Director responsibilities for Global medical devices. Multi-country manufacturing, cross-divisional, selling and distribution to the medical device industry across the US, Asia and EMEA. Johnson Matthey Medical Device Components provides a complete range of capabilities in the fabrication of precious metals, alloys and Nitinol. In addition to our technological capability, stringent quality standards and modern production methods are employed to guarantee our world class product range. Our sales service, technical assistance and reliability has also built an enviable reputation in the market as a trusted and dependable partner in industry.
Vice President and Managing Director, EMEA Leadership and Director responsibilities for region. RTI Surgical® is a leading global surgical implant company providing surgeons with safe biologic, metal and synthetic implants. Committed to delivering a higher standard, RTI’s implants are used in sports medicine, general surgery, spine, orthopedic, trauma and cardiothoracic procedures and are distributed in nearly 50 countries. RTI is headquartered in Alachua, Fla., and has four manufacturing facilities throughout the U.S. and Europe. Spine, Sports Medicine, Orthopaedics, Biologics, Cardio Thoracic, General Surgery, Abdominal, Breast, ENT